BioCentury
ARTICLE | Company News

MediGene, NeuroVir deal

January 22, 2001 8:00 AM UTC

MDG completed its previously announced acquisition of NeuroVir (see BioCentury, Nov. 13, 2000). MDG issued 996,631 shares in exchange for the 91 percent of NeuroVir it does not already own, valuing th...